NCT01754766View on ClinicalTrials.gov

AGN-229666 for the Treatment of Allergic Conjunctivitis

PHASE2CompletedINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

February 28, 2013

Conditions

Allergic Conjunctivitis

Interventions

DRUG

AGN-229666

One drop of AGN-229666 into each eye on Day 1 and Day 15.

OTHER

vehicle of AGN-229666

One drop of vehicle of AGN-229666 into each eye on Day 1 and Day 15.

Trial Locations (1)

Unknown

Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Allergan

INDUSTRY